You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EP2 antagonist

Showing 1 - 25 of 8,072
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Carcinoma (CRC), Endometrial Carcinoma (EC) Trial in Oklahoma City (TPST-1495)

Not yet recruiting
  • Colorectal Carcinoma (CRC)
  • Endometrial Carcinoma (EC)
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Nov 8, 2023

Childhood Absence Epilepsy, Juvenile Absence Epilepsy Trial in Worldwide (Brivaracetam Film-coated tablet, Brivaracetam oral

Enrolling by invitation
  • Childhood Absence Epilepsy
  • Juvenile Absence Epilepsy
  • Brivaracetam Film-coated tablet
  • Brivaracetam oral solution
  • Birmingham, Alabama
  • +21 more
Jan 5, 2023

SMART Protocol vs Antagonist Protocol in IVF

Active, not recruiting
  • Diminished Ovarian Reserve
    • Montreal, Quebec, Canada
      Clinique Ovo
    Dec 22, 2022

    Epilepsy Trial in Worldwide (Lacosamide Tablet, Lacosamide Oral Solution)

    Active, not recruiting
    • Epilepsy
    • Lacosamide Tablet
    • Lacosamide Oral Solution
    • Little Rock, Arkansas
    • +86 more
    Jan 3, 2023

    Healthy Trial in Madison (Selpercatinib, Ranitidine, Omeprazole)

    Completed
    • Healthy
    • Madison, Wisconsin
      Covance Clinical Research Unit, Inc.
    Jan 12, 2023

    Fibrolamellar Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, DRP-104)

    Not yet recruiting
    • Fibrolamellar Hepatocellular Carcinoma
    • Baltimore, Maryland
      Johns Hopkins SKCCC
    Aug 30, 2023

    Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)

    Recruiting
    • Chronic Inducible Urticaria
    • Oral EP262
    • Tampa, Florida
    • +5 more
    Sep 18, 2023

    Atopic Dermatitis Trial in Canada, United States (Oral EP262, Placebo)

    Recruiting
    • Atopic Dermatitis
    • Oral EP262
    • Placebo
    • Birmingham, Alabama
    • +9 more
    Nov 28, 2023

    Chronic Spontaneous Urticaria Trial in Canada, United States (Oral EP262, Placebo)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Oral EP262
    • Placebo
    • Birmingham, Alabama
    • +7 more
    Oct 5, 2023

    Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

    Not yet recruiting
    • Hormone Receptor-positive Breast Cancer
    • +2 more
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Oct 5, 2022

    Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

    Recruiting
    • Safety Issues
    • +2 more
    • Washington, District of Columbia
      Georgetown University
    Dec 1, 2022

    Rheumatoid Arthritis, DMARD-naive and Early Disease Patients Trial in Prague (CR6086, Methotrexate, Placebo)

    Completed
    • Rheumatoid Arthritis, DMARD-naive and Early Disease Patients
    • Prague, Czechia
      Institute of Rheumatology
    Oct 4, 2021

    Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer Trial in Milano

    Recruiting
    • Refractory Metastatic Colorectal Cancer
    • +3 more
    • Milano, MI, Italy
      Istituto Nazionale dei Tumori
    Jan 24, 2022

    Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    Pancreatitis, Acute Trial in Denmark, Sweden (Placebo treatment, Naldemedine 0.2 MG Oral Tablet)

    Recruiting
    • Pancreatitis, Acute
    • Placebo treatment
    • Naldemedine 0.2 MG Oral Tablet
    • Aalborg, Jutland, Denmark
    • +4 more
    Mar 7, 2022

    Dysarthria Trial in Barnsley (Communication aid support)

    Recruiting
    • Dysarthria
    • Communication aid support
    • Barnsley, United Kingdom
      Barnsley Hospital NHS Foundation Trust
    May 4, 2023

    Redo AF Sub Study (of the Pure EP 2.0 Main Study)

    Completed
    • Atrial Fibrillation Recurrent
    • Pure-EP
    • Austin, Texas
      St. David's Medical Center
    Feb 10, 2022

    in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

    Withdrawn
    • in Vitro Fertilization
    • Poor Responder
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    Apr 7, 2022

    Blood Flow Trial in Copenhagen (GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo)

    Recruiting
    • Blood Flow
    • GIPR antagonist / study tool
    • +2 more
    • Copenhagen, Denmark
      Rigshospitalet
    Nov 2, 2022

    Spinal Cord Injuries, Myelopathy Trial in Cambridge (Istradefylline, low oxygen therapy)

    Not yet recruiting
    • Spinal Cord Injuries
    • Myelopathy
    • Cambridge, Massachusetts
      Spaulding Rehabilitation Hospital
    Jun 24, 2022

    COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

    Recruiting
    • COVID-19
    • SARS-CoV2 Infection
    • Candesartan Cilexetil
    • +3 more
    • Guntur, India
    • +4 more
    Mar 13, 2022

    Infertility Trial (10000 IU hCG (Choriomon5000 IU; IBSA), Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring))

    Not yet recruiting
    • Infertility
    • 10000 IU hCG (Choriomon5000 IU; IBSA)
    • Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring)
    • (no location specified)
    May 27, 2022

    Dravet Syndrome Trial in Memphis (fenfluramine)

    Recruiting
    • Dravet Syndrome
    • Memphis, Tennessee
      Ep0213 105
    Nov 9, 2023

    Ovarian Stimulation Trial in Shibin Al Kawm (Letrozole 2.5mg tablet)

    Recruiting
    • Ovarian Stimulation
    • Letrozole 2.5mg tablet
    • Shibīn Al Kawm, Menoufia, Egypt
      Menoufia University hospital
    Dec 8, 2021

    Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

    Recruiting
    • Type 2 Diabetes
    • +2 more
    • San Antonio, Texas
      Texas Diabetes Institute
    Dec 22, 2021